Table 3.

Amount of malondialdehyde in Hep G2 cells preincubated with O. majorana essential oil and its oxygenated monoterpene component linalool before H₂O₂ treatment

Groups	MDA levels f (nmol/mg protein S.E.)
IC10 E.O + IC10 H2O2	0.56 0.04 ab
IC10 E.O + IC50 H2O2	0.92 0.07 ab
IC10 E.O + IC70 H2O2	1.60 0.14 cd
IC20 E.O + IC10 H2O2	0.42 0.03 a
IC20 E.O + IC50 H2O2	0.75 0.07 ab
IC20 E.O + IC70 H2O2	1.52 0.66 cd
IC30 E.O + IC10 H2O2	0.38 0.06 a
IC30 E.O + IC50 H2O2	0.68 0.07 ab
IC30 E.O + IC70 H2O2	1.38 0.03 bc
IC10 Linalool + IC10 H2O2	0.42 0.08 a
IC10 Linalool + IC50 H2O2	0.78 0.07 ab
IC10 Linalool + IC70 H2O2	1.43 0.34 bc
IC20 Linalool + IC10 H2O2	0.35 0.06 a
IC20 Linalool + IC50 H2O2	0.72 0.07 ab
IC20 Linalool + IC70 H2O2	1.30 0.03 bc
IC30 Linalool + IC10 H2O2	0.29 0.03 a
IC30 Linalool + IC50 H2O2	0.65 0.07 ab
IC30 Linalool + IC70 H2O2	1.17 0.55 bc
IC10 H2O2	0.65 0.07 ab
IC50 H2O2	1.1 0.08 b
IC70 H2O2	1.70 0.34 cd
Control	0.23 0.11 a
0.5 % DMSO	0.22 0.20 a

MDA; malondialdehyde, E.O; essential oil, S.E.; Standart Error.

^f Means (n=5) fallowed by different letters within column are significantly different (p≤ 0.05).